| ASSET | YEAR | % RETURN |
|---|---|---|
GeneDx (WGS) | 2024 | 2,815.19% |
Sezzle Inc Common Stock (SEZL) | 2024 | 2,109.43% |
Nuscale Power (SMR) | 2024 | 832.41% |
Avidity Biosciences (RNA) | 2024 | 379.49% |
Janux Therapeutics (JANX) | 2024 | 371.07% |
ADMA Biologics (ADMA) | 2024 | 370.67% |
Lumen Technologies (LUMN) | 2024 | 340.22% |
Ast Spacemobile (ASTS) | 2024 | 311.26% |
Sweetgreen (SG) | 2024 | 291.7% |
SoundHound AI (SOUN) | 2024 | 287.32% |
BBVA Banco Frances SA ADR (BBAR) | 2024 | 264.33% |
PureCycle Technologies (PCTTW) | 2024 | 259.65% |
Nextnav Acquisition (NN) | 2024 | 259.05% |
IES (IESC) | 2024 | 250.93% |
Grupo Financiero Galicia SA ADR (GGAL) | 2024 | 248.67% |
Argan (AGX) | 2024 | 245.68% |
Powell Industries (POWL) | 2024 | 234.93% |
United States Lime & Minerals (USLM) | 2024 | 231.13% |
Longboard Pharmaceuticals (LBPH) | 2024 | 223.59% |
Banco Macro SA B ADR (BMA) | 2024 | 221.5% |
Vera Therapeutics (VERA) | 2024 | 217.83% |
Lemonade (LMND) | 2024 | 208% |
Rush Street Interactive (RSI) | 2024 | 202.04% |
Purecycle Technologies (PCT) | 2024 | 195.3% |
Edgewise Therapeutics (EWTX) | 2024 | 194.6% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
